Item 8.01. Other Events.
As previously announced, on March 24, 2022, Accelerate Diagnostics, Inc. (the
"Company") entered into a securities purchase agreement (the "Securities
Purchase Agreement") with the Jack W. Schuler Living Trust (the "Schuler Trust")
for the issuance and sale by the Company of an aggregate of an aggregate of
2,439,024 shares of the Company's common stock (the "Shares") to the Schuler
Trust in an offering (the "Private Placement") exempt from registration pursuant
to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506
promulgated thereunder. Pursuant to the Securities Purchase Agreement, the
closing of the Private Placement was to occur on June 30, 2022 (the "Closing
Date"), subject to the satisfaction of customary closing conditions. On June 29,
2022, the Company and the Schuler Trust agreed to extend the Closing Date to
September 26, 2022. All other terms of the Securities Purchase Agreement remain
unchanged.
© Edgar Online, source Glimpses
ACCELERATE DIAGNOSTICS, INC. 
